You searched for "innovation"

2436 results found

Orbis celebrates International Day of Friendship

International eyecare charity Orbis recognises the importance of strong bonds on International Day of Friendship 2023.

The African Ophthalmology Council: Driving excellence in African eye health

Have you been wondering about how you can impact, or even just understand, the eyecare landscape in Africa from those who experience it daily? Ever wondered about which one body brings all eye health professionals in Africa together, united in...

Internuclear ophthalmoplegia: a case study

A 44-year-old patient presents with binocular, mostly horizontal diplopia when fixating on moving objects. This has been ongoing for approximately five years. He is known to have multiple sclerosis and had an episode of optic neuritis six years prior in...

CHEC expands transformative MIGS service

CHEC, a community healthcare provider delivering specialist ophthalmology services on behalf of the NHS, has announced the expansion of its minimally invasive glaucoma surgery (MIGS) service. MIGS is an innovative approach combining glaucoma treatment with cataract surgery, utilising advanced techniques...

Stent inject® W shelf life extended from 12 months to three years

Glaukos is delighted to announce that the expiry date for their innovative iStent inject® W device has been increased from 12 months to three years.

Conor Lavery promoted to Glaukos National Field Sales Manager, UK and Ireland

Glaukos is delighted to announce the promotion of Conor Lavery to National Field Sales Manager UK & Ireland, in his new role he will manage the Sales teams in these counties and provide support to Northern Europe management.

My Top Five: Innovations in the diagnosis of ocular tumours

Ocular tumours can vary widely in origin, from benign growths to metastases from distant disseminated malignancies. Although rare, ocular tumours pose a significant health and economic burden globally, with ocular cancers accounting for 0.2% of all diagnosed malignancies in the...

Real world data of post-IVT endophthalmitis, from a nurse-delivered intravitreal injection service

Introduction Intravitreal injection of neutralising anti-vascular endothelial growth factor (VEGF) antibody was licenced more than a decade ago, and over the years there has been proportionate increase in the number of intravitreal injections [1]. Injection of a therapeutic agent through...

AI-Based devices in national screening programmes: barriers and challenges

Diabetic retinopathy (DR) may have long-term complications and is recorded as a leading cause of blindness. National DR screening programmes have effectively reduced severe visual loss by timely detection and subsequent treatment of sight-threatening proliferative DR and diabetic macular oedema....

Congenital and paediatric cataract: Advances in diagnosis and management

Congenital and paediatric cataracts are relatively rare, although prevalence varies significantly between countries, influenced by factors such as nutrition, immunisation policy and population genetics [1]. In the UK, around 3–4 of every 10,000 babies are born with cataracts. It’s a...

ANZGS Congress 2025

As Chair of the Australian and New Zealand Glaucoma Society I am pleased to invite you to the 2025 ANZGS Congress which will be held in Perth from 14 – 16 February 2025. Following the triumph of the well-attended 2024...

Enter the Dragons’ Den: Bob Gokani

I have often daydreamed about inventing a successful new product and then going on to pitch for investment on Dragons’ Den, with the TV show’s seasoned entrepreneurs all competing with each other to invest in my company. My imagined fantasy...